| Literature DB >> 36090332 |
Eva K Egger1, Freya Merker1, Damian J Ralser1, Milka Marinova2, Tim O Vilz3, Hanno Matthaei3, Tobias Hilbert4, Alexander Mustea1.
Abstract
Aim: This study aims to evaluate the incidence of postoperative ileus (POI) following cytoreductive surgery in epithelial ovarian cancer (EOC) patients and its impact on anastomotic leakage occurrence and postoperative complications.Entities:
Keywords: anastomotic leakage; complications; ovarian cancer; paralytic ileus; surgical complexity
Year: 2022 PMID: 36090332 PMCID: PMC9448895 DOI: 10.3389/fsurg.2022.976497
Source DB: PubMed Journal: Front Surg ISSN: 2296-875X
General patients’ characteristics.
| Factor | Number of patients |
|---|---|
| Primary disease | 294 (82.4%) |
| Recurrent disease | 63 (17.6%) |
| Histology | Serous: 310 (86.8%) |
| Endometriod: 24 (6.7%) | |
| Clear cell: 5 (1.4%) | |
| Mucinous: 18 (5.0%) | |
| Age-adjusted comorbidity index | 0:54 (15.1%) |
| 1:77 (21.6%) | |
| 2: 91 (25.5%) | |
| 3:68 (19%) | |
| 4:36 (10.1%) | |
| 5:20 (5.6%) | |
| 6:4 (1.1%) | |
| 7:5 (1.4%) | |
| 8:1 (<1%) | |
| 10: 1 (<1%) | |
| Median number of previous surgeries | 1 (range: 0–3) |
| BMI | >40:15 (4.3%) |
| >30:58 (16.8%) | |
| >24:119 (33.52%) | |
| >19: 155 (44.8%) | |
| <19:10 (2.9%) | |
| No residual tumor | 256 (71.7%) |
| Residual tumor below 5 mm | 40 (11.2%) |
| Residual tumor below 2 cm | 38 (10.6%) |
| Residual tumor >2 cm | 20 (5.6%) |
| FIGO stages | I: 64 (17.9%) |
| II: 20 (5.6%) | |
| IIIA: 12 (3.4%) | |
| IIIB: 17 (4.8%) | |
| IIIC: 207 (58%) | |
| IVA: 34 (9.5%) | |
| IVB: 3 (<1%) | |
| Lymphonodectomy | 211 (59.1%) |
| No. of patients with bowel resections | 169 (47.3%) |
| No. of patients with anastomoses | 165 (46.2%) |
| Peridural anesthesia | 303 (84.87%) |
| Patient controlled morphine analgesy | 19 (5.3%) |
| Primary debulking surgery | 241 (67.5%) |
| Interval debulking after chemotherapy | 116 (32.5%) |
199 Anastomoses.
| Anastomosis | Leakage | No leakage |
|---|---|---|
| Jejeunojejunostomy | 0 | 6 |
| Ileoileostomy | 0 | 17 |
| Descendorectostomy | 18 | 99 |
| Ileoascendostomy | 3 | 25 |
| Transversotransversostomy | 0 | 3 |
| Transversorectostomy | 1 | 8 |
| Ileorectostomy | 1 | 8 |
| Ascendorectostomy | 0 | 5 |
| Jejunotransversostomy | 1 | 0 |
First defecation after surgery.
| Days after surgery | Number of patients with first postoperative defecation |
|---|---|
| 0 (Day of surgery) | 7 |
| 1 | 41 |
| 2 | 68 |
| 3 | 117 |
| 4 | 82 |
| 5 | 27 |
| 6 | 11 |
| 7 | 3 |
Factors with increased and decreased POI rates.
| Factors associated with a decreased rate of POI | |
|---|---|
| Postoperative antibiotics | 0.001 |
| Stoma creation | 0.0001 |
| Start with laxatives on the first postoperative day | 0.0048 |
| Factors associated with an increased rate of POI | |
| Positive fluid excess > 5,000 cc vs. | 0.0063 |
| Rectal anastomosis | 0.0143 |
| Anastomosis in general | 0.0465 |
| Factors without significant influence on POI | |
| Primary vs. recurrent disease | 0.7692 |
| Charlson comorbidity index >8 vs. <8 | 0.5453 |
| Preoperative laxatives | 1.000 |
| No preoperative laxatives | 0.7187 |
| Preoperative clysma only | 0.1228 |
| Preoperative antibiotics | 1.000 |
| PCI > 15 | 0.8964 |
| Residual tumor | 0.8964 |
| Lymphonodectomy | 0.3642 |
| Surgical complexity score grading of 3 | 0.2631 |
| Neoadjuvant chemotherapy | 0.0750 |
| Noradrenalin intraoperative >20 µg/ml | 0.3019 |
| Peridural catheter | 0.1271 |
| Patient-controlled analgesia | 0.1271 |
| Kalium >4 mg/L | 0.2378 |
POI, postoperative ileus.
Postoperative morbidity, hospital stay, fluid balance, and anastomotic leakage.
| Morbidity | Hospital stay: <17 days | Hospital stay >17 days |
|---|---|---|
| G0–3 | 227 | 95 |
| G4–G5 | 6 | 29 |
| Anastomotic leakage | Hospital stay: <17 days | Hospital stay > 17 days |
| Yes | 0 | 24 |
| No | 88 | 53 |
| Anastomotic leakage | Fluid balance > 5,000 cc | Fluid balance < 5,000 cc |
| Yes | 21 | 3 |
| No | 217 | 115 |
| Morbidity | Fluid balance > 5,000 cc | Fluid balance < 5,000 cc |
| G0–G2 | 147 | 93 |
| G3–G5 | 91 | 25 |
Logistic regression table.
| Predictor | Odds ratio | 95% CI |
|---|---|---|
| Comorbidity | ||
| 1 | 2.97 | 1.05–8.42 |
| 2 | 1.79 | 0.70–4.54 |
| 3 | 3.23 | 1.20–8.68 |
| 4 | 1.62 | 0.52–5.05 |
| 5 | 1.37 | 0.29–6.37 |
| 6 | 0.15 | 0.02–1.42 |
| 7 | 1.57 | 0.12–21.29 |
| Surgical complexity grouped | ||
| 2 | 1.14 | 0.24–5.39 |
| 3 | 0.69 | 0.15–3.16 |
POI and anastomoses.
| Factor | |
|---|---|
| Low rectal anastomoses vs. no anastomosis and POI |
|
| Small bowel anastomosis vs. no anastomosis and POI | 1.000 |
| Anastomosis in general vs. no anastomosis and POI | |
| Anastomotic leakage vs. no leakage and POI | 0.3341 |
| Low rectal anastomosis and leakage vs. no leakage and POI | 0.1589 |
| Anastomotic leakage vs. no leakage | 0.3341 |
| Large bowel anastomosis vs. small bowel anastomosis only | 0.3341 |
| Anastomotic leakage considering only patients without stoma (day 4) | 0.5405 |
| Increasing surgical complexity in patients with rectal anastomoses and without stoma creation | 1.000 |
POI, postoperative ileus.